| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jerzy Windyga | Q87941922 |
| Victor S. Blanchette | Q106606296 | ||
| Alessandro Casini | Q85554135 | ||
| P2093 | author name string | Ingrid Pabinger | |
| Barbara Zieger | |||
| Francesco Rodeghiero | |||
| Patrizia Noris | |||
| Mike Makris | |||
| Paolo Gresele | |||
| Riitta Lassila | |||
| Frank Leebeek | |||
| Alok Srivastava | |||
| Erik Berntorp | |||
| David Lillicrap | |||
| Alberto Tosetto | |||
| Diego Mezzano | |||
| Nigel Key | |||
| Imre Bodó | |||
| Rezan Abdul-Kadir | |||
| Margaret Ragni | |||
| P2860 | cites work | Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project | Q30848055 |
| A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop) | Q34209350 | ||
| Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. | Q34336631 | ||
| Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults | Q34474318 | ||
| Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis | Q34750409 | ||
| Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status | Q35095095 | ||
| Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease | Q36369902 | ||
| Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function | Q36371688 | ||
| Aspects of the laboratory identification of von Willebrand disease in women | Q36544689 | ||
| Patients Referred for Bleeding Symptoms of Unknown Cause: Does Evaluation of Thrombin Generation Contribute to Diagnosis? | Q36630802 | ||
| How to estimate bleeding risk in mild bleeding disorders | Q36884367 | ||
| Approach to the diagnosis and management of mild bleeding disorders | Q36884373 | ||
| Review of quality of life: menorrhagia in women with or without inherited bleeding disorders | Q36981726 | ||
| The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels | Q37043558 | ||
| Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease | Q37078888 | ||
| Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology | Q37084857 | ||
| Impact of genetic variation on perioperative bleeding | Q37174998 | ||
| A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders | Q37243310 | ||
| The evolution and value of bleeding assessment tools | Q37484489 | ||
| Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause | Q37620112 | ||
| Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium | Q37889006 | ||
| Bleeding scores: are they really useful? | Q38066861 | ||
| Is my patient a bleeder? A diagnostic framework for mild bleeding disorders | Q38066910 | ||
| The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review | Q89006379 | ||
| Diagnosis of hereditary platelet disorders in the era of next-generation sequencing: "primum non nocere" | Q90914830 | ||
| The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH | Q91292530 | ||
| Simplifying the diagnosis of inherited platelet disorders? The new tools do not make it any easier | Q92282421 | ||
| The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH | Q93087951 | ||
| Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. | Q38268811 | ||
| Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin | Q38595760 | ||
| Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. | Q38695989 | ||
| Feasibility of the Von Willebrand disease PREVENT trial. | Q38747172 | ||
| Inherited Platelet Function Disorders: Algorithms for Phenotypic and Genetic Investigation. | Q38768215 | ||
| A diagnostic approach to mild bleeding disorders | Q38840603 | ||
| Heavy menstrual bleeding: An update on management | Q39163239 | ||
| Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding | Q41353573 | ||
| Bleeding risk of surgery and its prevention in patients with inherited platelet disorders | Q41480992 | ||
| Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey | Q41517371 | ||
| Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. | Q42572887 | ||
| Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction? | Q44385751 | ||
| Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas | Q44605551 | ||
| Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease | Q45145414 | ||
| von Willebrand disease and bleeding in women | Q45863706 | ||
| The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease | Q45864717 | ||
| Definitions in hemophilia: communication from the SSC of the ISTH. | Q45867149 | ||
| Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis | Q45869529 | ||
| The ISTH Bleeding Assessment Tool and the risk of future bleeding. | Q45873528 | ||
| Pregnancy in women with von Willebrand's disease or factor XI deficiency | Q45886261 | ||
| High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB). | Q47547484 | ||
| Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels | Q47793791 | ||
| Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding | Q47863997 | ||
| Health-related quality of life among adult patients with moderate and severe von Willebrand disease | Q48852651 | ||
| Hereditary thrombocytopenias: a growing list of disorders | Q49989075 | ||
| Thrombin generation in patients with a bleeding tendency of unknown origin. | Q51498709 | ||
| Beighton Score: A Valid Measure for Generalized Hypermobility in Children | Q51751475 | ||
| The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. | Q51958036 | ||
| MYH9 gene mutations associated with bleeding. | Q52884676 | ||
| Prevention and Management of Postpartum Haemorrhage | Q56674877 | ||
| A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) | Q59511676 | ||
| von Willebrand disease and aging: an evolving phenotype | Q62107242 | ||
| Thrombopoietin receptor agonists in hereditary thrombocytopenias. | Q64931569 | ||
| Preoperative hemostatic evaluation: which tests, if any? | Q71651335 | ||
| High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls | Q79879709 | ||
| Interactions between genotype and phenotype in bleeding and thrombosis | Q81198042 | ||
| Diagnosis and management of mild bleeding disorders | Q81520305 | ||
| What is value in health care? | Q82807569 | ||
| Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation | Q83704000 | ||
| Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire | Q84002500 | ||
| ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders | Q84564581 | ||
| Room for improvement in national academy of clinical biochemistry laboratory medicine practice guidelines | Q84808305 | ||
| Unexplained bleeding: another player to look out for! | Q86568363 | ||
| P433 | issue | 5 | |
| P304 | page(s) | e286 | |
| P577 | publication date | 2019-09-17 | |
| P1433 | published in | HemaSphere | Q73378695 |
| P1476 | title | Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report | |
| P478 | volume | 3 |
Search more.